Overview
Xicheng Wang practices in Guangzhou, China. Wang is rated as an Experienced expert by MediFind in the treatment of Myelofibrosis. Their top areas of expertise are Nasopharyngeal Carcinoma, Non-Small Cell Lung Cancer (NSCLC), Lung Cancer, and Small Cell Lung Cancer (SCLC).
Their clinical research consists of co-authoring 48 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 2 articles in the study of Myelofibrosis.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
1 Clinical Trials
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Liver CancerWang isExperienced. Learn about Liver Cancer.
- Lung CancerWang isExperienced. Learn about Lung Cancer.
- MyelofibrosisWang isExperienced. Learn about Myelofibrosis.
- Nasopharyngeal CarcinomaWang isExperienced. Learn about Nasopharyngeal Carcinoma.
- Non-Small Cell Lung Cancer (NSCLC)
- Small Cell Lung Cancer (SCLC)